Pharmaceuticals and Cosmetics
Reliable guidance in a highly sensitive environment
Heissner & Struck advises companies from both the pharmaceuticals and cosmetics industry. The pharmaceuticals and cosmetics industry operates in a highly sensitive environment with regard to communication and the law, in which all advertising statements, research projects and patient programs, all product marketing and labeling and its distribution involves legal questions. We assist our clients with binding legal recommendations, provide support for marketing and contractual issues and help them avoid or successfully handle disputes with competitors or supervisory authorities.
Our service offer
Our legal advice for pharmaceuticals companies focuses on drug advertising laws. We counsel our clients on the wording of advertising texts and the preparation of various means of distribution and communication, defend them in disputes with competitors and, if required, stop competitors‘ unlawful advertising statements.
We also support our clients in contractual matters, whether it is in the field of medical research, cooperation with universities or communication with patients, such as patient programs and information and distribution law concerns.
Our clients from the cosmetics industry receive comprehensive advice. Typical questions include the design of packaging and mandatory information, the review of the permissibility of advertising statements, the drafting of contracts with manufacturers, suppliers and distributors and legal protection, particularly for online distribution businesses.
In addition, we can provide our clients with support for the establishment of new brand products from the selection of a patentable brand to its international registration.
We assist our clients with all contract negotiations as well as in out of court and in court disputes.
Dr. Fabian Ropohl
P: (Personal Assistant) +49(40) 413 05 38-21
Dr. Christian Lemke
P: (Personal Assistant) +49(40) 413 05 38-16
Experts for pharmaceutical advertisement
Defense of a pharmaceutical company in expedited proceedings against attacks from competitors who contested violations of competition law and drug advertisement law. Subsequently, precautionary review of various other advertising statements with consideration given to sufficient scientific substantiation, followed by counseling on the redesign of various advertising materials.